# Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

> **NCT03904134** · NA · COMPLETED · sponsor: **Center for International Blood and Marrow Transplant Research** · enrollment: 1753 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Non-hodgkin Lymphoma
- Hodgkin Lymphoma
- Acquired Aplastic Anemia
- Sickle Cell Disease

## Interventions

- **OTHER:** Donor Search Prognosis Score

## Key facts

- **NCT ID:** NCT03904134
- **Lead sponsor:** Center for International Blood and Marrow Transplant Research
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-14
- **Primary completion:** 2025-01-06
- **Final completion:** 2025-01-06
- **Target enrollment:** 1753 (ACTUAL)
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03904134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03904134, "Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03904134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*